Tumor Microenvironment in Ovarian Cancer

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-80
SponsorUniversity of Udine

About this trial

A detailed understanding of molecular mechanism of cancer genesis is fundamental to develop innovative and personalized therapies. The new frontier in biomedical research is represented by organoids, a three-dimensional cell culture system obtained from a tissue fragment that accurately reproduces the essential properties of the original tissue in vitro, which could provide a valuable model for explanation of ovarian cancers pathogenesis and will allow to predict the response to a specific therapy. With this research project, we expect to generate ovarian cancer organoids to characterize in vitro interactions and molecular pathway among tumor cells, immune cells, and resident microbiota (intratumoral bacteria and/or microbial-derived molecules).

Eligibility criteria

Qualifiers

Age > 18 years

Age < 80 years

Serous ovarian carcinoma

FIGO Stage III-IV

Disqualifiers

Ongoing or suspended immunosuppressive therapy within the last 6 months

Congenital or acquired immunodeficiency

Immunosuppressive state

Administration of chemotherapy for another neoplasm in the past 12 months

Trial design

Treatments tested in this trial

  • Ovarian Cancer Organoids

Treatment groups

No treatment groups listed

Sponsors and collaborators